These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36830578)

  • 1. Prognostic Biomarker SPOCD1 and Its Correlation with Immune Infiltrates in Colorectal Cancer.
    Gan L; Yang C; Zhao L; Wang S; Gao Z; Ye Y
    Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of
    Yavari S; Naseroleslami M; Peymani M; Yekani F; Khayam Nekouei N
    Cell J; 2024 Jul; 26(5):309-319. PubMed ID: 39066595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of
    Lin Z; Chen L; Wu T; Zhang Y; Huang X; Chen Y; Chen J; Xu Y
    Front Genet; 2022; 13():872026. PubMed ID: 35646092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPOCK1 and POSTN are valuable prognostic biomarkers and correlate with tumor immune infiltrates in colorectal cancer.
    Gan C; Li M; Lu Y; Peng G; Li W; Wang H; Peng Y; Hu Q; Wei W; Wang F; Liu L; Zhao Q
    BMC Gastroenterol; 2023 Jan; 23(1):4. PubMed ID: 36611136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPOCD1 promotes the proliferation and metastasis of glioma cells by up-regulating PTX3.
    Liu Q; Wang XY; Qin YY; Yan XL; Chen HM; Huang QD; Chen JK; Zheng JM
    Am J Cancer Res; 2018; 8(4):624-635. PubMed ID: 29736308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UBTD1 is a potential prognostic biomarker in colorectal cancer.
    Zhao Z; Yang C; Geng X; Yuan C; Yang R; Yang G
    Sci Rep; 2024 Aug; 14(1):17926. PubMed ID: 39095643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MTUS1 is a promising diagnostic and prognostic biomarker for colorectal cancer.
    Cheng LY; Huang MS; Zhong HG; Ru HM; Mo SS; Wei CY; Su ZJ; Mo XW; Yan LH; Tang WZ
    World J Surg Oncol; 2022 Aug; 20(1):257. PubMed ID: 35962436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer.
    Wang D; Liufu J; Yang Q; Dai S; Wang J; Xie B
    Biol Direct; 2022 Nov; 17(1):29. PubMed ID: 36319976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
    Yue Y; Zhang Q; Sun Z
    Front Immunol; 2021; 12():758040. PubMed ID: 35140706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPOCD1 accelerates ovarian cancer progression and inhibits cell apoptosis via the PI3K/AKT pathway.
    Liu D; Yang Y; Yan A; Yang Y
    Onco Targets Ther; 2020; 13():351-359. PubMed ID: 32021280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated Analysis of Expression and Prognostic Values of Acyl-CoA Dehydrogenase short-chain in Colorectal Cancer.
    Wu Q; Yan T; Chen Y; Chang J; Jiang Y; Zhu D; Wei Y
    Int J Med Sci; 2021; 18(16):3631-3643. PubMed ID: 34790035
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor microenvironment-related gene selenium-binding protein 1 (SELENBP1) is associated with immunotherapy efficacy and survival in colorectal cancer.
    Zhu C; Wang S; Du Y; Dai Y; Huai Q; Li X; Du Y; Dai H; Yuan W; Yin S; Wang H
    BMC Gastroenterol; 2022 Oct; 22(1):437. PubMed ID: 36253721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
    Yang C; Cao F; Huang S; Zheng Y
    Front Immunol; 2021; 12():717505. PubMed ID: 34335633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The possible role of SRMS in colorectal cancer by bioinformatics analysis.
    Zhang J; Liu W; Feng S; Zhong B
    World J Surg Oncol; 2021 Nov; 19(1):326. PubMed ID: 34781983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer development is affected by the ECM molecule EMILIN-2 hinging on macrophage polarization via the TLR-4/MyD88 pathway.
    Andreuzzi E; Fejza A; Polano M; Poletto E; Camicia L; Carobolante G; Tarticchio G; Todaro F; Di Carlo E; Scarpa M; Scarpa M; Paulitti A; Capuano A; Canzonieri V; Maiero S; Fornasarig M; Cannizzaro R; Doliana R; Colombatti A; Spessotto P; Mongiat M
    J Exp Clin Cancer Res; 2022 Feb; 41(1):60. PubMed ID: 35148799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of LAGE3 correlates with prognosis and immune infiltrates in colorectal cancer: A bioinformatic analysis.
    Dong X; Lv S; Zhang X; Hao R
    Int Immunopharmacol; 2020 Aug; 85():106599. PubMed ID: 32438075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPOCD1 promotes cell proliferation and inhibits cell apoptosis in human osteosarcoma.
    Liang J; Zhao H; Hu J; Liu Y; Li Z
    Mol Med Rep; 2018 Feb; 17(2):3218-3225. PubMed ID: 29257309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.
    Li T; Yan Z; Wang W; Zhang R; Gan W; Lv S; Zeng Z; Hou Y; Yang M
    Front Mol Biosci; 2021; 8():687319. PubMed ID: 34938771
    [No Abstract]   [Full Text] [Related]  

  • 20. Interferon regulatory factor family influences tumor immunity and prognosis of patients with colorectal cancer.
    Chen YJ; Luo SN; Dong L; Liu TT; Shen XZ; Zhang NP; Liang L
    J Transl Med; 2021 Sep; 19(1):379. PubMed ID: 34488791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.